Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transcription factor 7 like 2 | 0.485 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.965 | 25 | 9 | 2006 | 2020 | ||||||||
|
translocase of outer mitochondrial membrane 40 | 0.590 | 0.538 | 0.99 |
|
disease | 0.500 | None | 0.978 | 17 | 14 | 2009 | 2020 | ||||||||
|
interleukin 23 receptor | 0.466 | 0.769 | 5.6E-04 |
|
disease | 0.700 | None | 0.950 | 13 | 19 | 2006 | 2020 | ||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.200 | None | 1.000 | 12 | 23 | 2007 | 2020 | |||||||||
|
cancer susceptibility 16 | 0.780 | 0.308 |
|
disease | 0.200 | None | 1.000 | 11 | 4 | 2007 | 2020 | |||||||||
|
synuclein alpha | 0.427 | 0.885 | 0.88 |
|
disease | 0.700 | None | 0.983 | 11 | 32 | 1997 | 2020 | ||||||||
|
FTO alpha-ketoglutarate dependent dioxygenase | 0.486 | 0.885 | 8.4E-08 |
|
disease | 0.500 | None | 0.954 | 11 | 16 | 2007 | 2020 | ||||||||
|
FTO alpha-ketoglutarate dependent dioxygenase | 0.486 | 0.885 | 8.4E-08 |
|
disease | 0.500 | None | 0.953 | 10 | 58 | 2007 | 2020 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
disease | 0.700 | None | 0.942 | 9 | 11 | 1991 | 2020 | ||||||||
|
autophagy related 16 like 1 | 0.543 | 0.769 | 0.96 |
|
disease | 0.700 | None | 0.953 | 8 | 5 | 2001 | 2020 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.700 | None | 0.961 | 8 | 8 | 2002 | 2020 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.200 | None | 0.927 | 7 | 4 | 1982 | 2020 | ||||||||
|
cholinergic receptor nicotinic alpha 3 subunit | 0.588 | 0.692 | 1.4E-07 |
|
disease | 0.500 | None | 1.000 | 6 | 7 | 2008 | 2020 | ||||||||
|
C-type lectin domain containing 16A | 0.612 | 0.654 | 0.28 |
|
disease | 0.500 | None | 1.000 | 6 | 15 | 2007 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.936 | 6 | 4 | 1989 | 2020 | ||||||||
|
BLK proto-oncogene, Src family tyrosine kinase | 0.585 | 0.769 | 8.3E-14 |
|
disease | 0.700 | None | 0.976 | 6 | 3 | 2008 | 2020 | ||||||||
|
complement C3 | 0.445 | 0.885 | 0.90 |
|
disease | 0.700 | limited | 1.000 | 6 | 1 | 2007 | 2020 | ||||||||
|
leucine rich repeat kinase 2 | 0.510 | 0.808 | 2.6E-30 |
|
disease | 0.500 | None | 0.983 | 5 | 5 | 2002 | 2020 | ||||||||
|
C9orf72-SMCR8 complex subunit | 0.496 | 0.769 | 1.1E-06 |
|
disease | 0.800 | limited | 0.985 | 5 | 13 | 2009 | 2020 | ||||||||
|
ankyrin 3 | 0.578 | 0.654 | 1.00 |
|
disease | 0.700 | None | 1.000 | 5 | 31 | 2008 | 2020 | ||||||||
|
regulator of telomere elongation helicase 1 | 0.459 | 0.808 | 8.9E-10 |
|
disease | 0.500 | None | 1.000 | 5 | 3 | 2009 | 2020 | ||||||||
|
wolframin ER transmembrane glycoprotein | 0.528 | 0.846 | 1.6E-38 |
|
disease | 0.700 | strong | 0.974 | 5 | 5 | 2002 | 2020 | ||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.800 | 5 | 4 | 2008 | 2020 | ||||||||
|
clusterin | 0.426 | 0.885 | 7.8E-05 |
|
disease | 0.500 | None | 0.940 | 4 | 5 | 1991 | 2020 | ||||||||
|
interleukin 23 receptor | 0.466 | 0.769 | 5.6E-04 |
|
disease | 0.700 | None | 0.982 | 4 | 3 | 2006 | 2020 |